Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/27/2014US20140088059 Compositions and Methods for Localized Drug Delivery through Mammary Papillae
03/27/2014US20140088058 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
03/27/2014US20140088044 Product comprising a nicotine-containing material and an anti-cancer agent
03/27/2014US20140088039 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
03/27/2014US20140088026 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088025 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088014 Freeze-dried preparation containing high-purity pth and method for producing same
03/27/2014US20140088003 Polymer-based sustained release device
03/27/2014US20140087060 Process For Producing A Solid Dispersion Of An Active Ingredient
03/27/2014US20140086997 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
03/27/2014US20140086996 Water-soluble drug carrier and process for producing the same
03/27/2014US20140086995 Polymer microsphere compositions for localized delivery of therapeutic agents
03/27/2014US20140086994 Synthesis of Small Particles
03/27/2014US20140086992 Storage-Stable Dust-Free Homogeneous Particulate Formulation
03/27/2014US20140086991 Controlled Agglomeration
03/27/2014US20140086988 Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them
03/27/2014US20140086987 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
03/27/2014US20140086984 Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative thereof
03/27/2014US20140086983 Methods for the preparation of liposomes comprising drugs
03/27/2014US20140086980 Treatment of erectile dysfunction and other indications
03/27/2014US20140086979 Self-Assembling Nanoparticles for the Release of Bisphosphonates in the Treatment of Human Cancers
03/27/2014US20140086978 Transdermal Therapeutic System Provided With Improved Long-Term Carrying Comfort
03/27/2014US20140086975 Hydrogel formulation for dermal and ocular delivery
03/27/2014US20140086974 Biodegradable drug delivery systems for the sustained release of proteins
03/27/2014US20140086973 Pharmaceutical preparation
03/27/2014US20140086972 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2014US20140086940 Herceptin® adjuvant therapy
03/27/2014US20140086931 Formulation of human antibodies for treating tnf-alpha associated disorders
03/27/2014US20140086930 Formulation of human antibodies for treating tnf-alpha associated disorders
03/27/2014US20140086929 Formulation of human antibodies for treating tnf-alpha associated disorders
03/27/2014US20140086900 Lyophilized Preparation of Botulinum Toxin
03/27/2014US20140086848 Foamable compositions and methods for disorders of the skin or mucosal surfaces
03/27/2014US20140086847 Dosage form that is safeguarded from abuse
03/27/2014US20140083890 Packaging material and package structure using the same
03/27/2014DE102012019029A1 Pharmaceutical formulation prepared by dissolving adjuvant in polyethylene glycols, useful for administration of active multiple charged anions e.g. heparin or its derivative, oligosaccharide or polysaccharide and nucleic acid sequence
03/26/2014EP2711374A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
03/26/2014EP2711369A1 Liposomes containing tetraether lipid derivatives
03/26/2014EP2711174A1 Packaging material and package structure using the same
03/26/2014EP2711050A1 Compound and cosmetic preparation with such a compound
03/26/2014EP2711010A1 Pharmaceutical composition
03/26/2014EP2711006A1 Product Comprising a Nicotine-Containing Material and an Anti-Cancer Agent
03/26/2014EP2711005A1 Compound dual-release capsule formulation comprised of bromodihydroarteisinin and fe2+ agent
03/26/2014EP2711002A2 Patch containing rivastigmine
03/26/2014EP2711001A2 Organogel compositions and processes for producing
03/26/2014EP2711000A1 Targeted Liposomes
03/26/2014EP2710999A1 Stable ophthalmic formulations
03/26/2014EP2710998A1 Clay-based aromatised therapeutic composition
03/26/2014EP2709648A2 Compounds that bind to the erythropoietin receptor
03/26/2014EP2709633A1 Method of treatment or prophylaxis of bacterial vaginosis
03/26/2014EP2709623A2 Medicaments and methods for treating cancer
03/26/2014EP2709617A1 The use of secnidazole in treating dental infections
03/26/2014EP2709610A1 High concentration olopatadine ophthalmic composition
03/26/2014EP2709601A1 Method for making customised nanoparticles, nanoparticles and uses thereof
03/26/2014EP2709600A1 Pharmaceutical composition comprising fexofenadine
03/26/2014EP2709599A1 Pharmaceutical composition comprising drotaverine
03/26/2014EP2709598A1 Pharmaceutical composition comprising ketoprofen
03/26/2014EP2709597A2 Drug delivery system
03/26/2014EP2709596A1 Effervescent formulations comprising dexketoprofen
03/26/2014EP2709595A1 Ifn-beta compositions, preparation methods and uses thereof
03/26/2014EP2709594A1 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
03/26/2014EP2709593A2 Multi-particulate pharmaceutical composition
03/26/2014EP2709592A1 Pharmaceutical composition of rosuvastatin calcium
03/26/2014EP2709591A1 Delivery of coated hydrophobic active agent particles
03/26/2014EP2709590A1 Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor
03/26/2014EP2709589A1 Charge triggering of self-organized nanoparticles
03/26/2014EP2709588A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration
03/26/2014EP2709587A2 Water-soluble formulations comprising dexketoprofen
03/26/2014EP2709447A1 Compositions, methods & systems for respiratory delivery of two or more active agents
03/26/2014CN203494017U Targeted information gas preparing device
03/26/2014CN203493942U Composite graphene hydrogel medicine carrier
03/26/2014CN203493940U Multi-effect patch and combined patch box consisting of same
03/26/2014CN1997388B Mucinous glycoprotein (MUC-1) vaccine
03/26/2014CN103687622A Multi-vinylsulfone containing molecule
03/26/2014CN103687610A Wound debridement compositions containing seaprose and methods of wound treatment using same
03/26/2014CN103687596A Solid pharmaceutical composition
03/26/2014CN103687594A Ophthalmic treatments
03/26/2014CN103687592A Pharmaceutical composition comprising fexofenadine
03/26/2014CN103687591A Capsule formulation comprising montelukast and levocetirizine
03/26/2014CN103687590A Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/26/2014CN103687589A Cb-183,315 compositions and related methods
03/26/2014CN103687588A Charge triggering of self-organized nanoparticles
03/26/2014CN103687587A Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
03/26/2014CN103687496A Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof
03/26/2014CN103687483A Compositions, methods & systems for respiratory delivery of two or more active agents
03/26/2014CN103675152A Nitroglycerin micro-emulsion spray content assaying method and application
03/26/2014CN103665697A Nanoparticle and polymer composite particle and application thereof
03/26/2014CN103656679A Preparation method of nano-particles
03/26/2014CN103656669A Compound micelle-based nano-vector, and preparation method and application thereof
03/26/2014CN103656668A Bortezomib sustained-release preparation and preparation method thereof
03/26/2014CN103656661A Porcine Japanese encephalitis live vaccine heat-resistant lyophilized protective agent as well as preparation method and application thereof
03/26/2014CN103656660A Heat-resistant freeze-drying protective agent for animal live vaccine, preparation method and application thereof
03/26/2014CN103656658A Drug for treating intestinal disease and preparation method thereof
03/26/2014CN103656657A Teriflunomide drug composition and preparation method
03/26/2014CN103656656A Sorafenib tosylate pharmaceutical composition and preparation method
03/26/2014CN103656655A Empty capsule and preparation method thereof
03/26/2014CN103656654A Instant orally-disintegrating tablet and its preparation method
03/26/2014CN103656652A Dual-sensing response type polymer nano-micelle as well as preparation method and application thereof
03/26/2014CN103656651A Drug-loaded composite microsphere and preparation method thereof
03/26/2014CN103656647A Effective prescription for radically treating diabetes
03/26/2014CN103656630A Method for purifying plasmin in animal medicine and preparing traditional Chinese medicine composition
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 2991